Targeting TRPC channels for control of arthritis-induced bone erosion

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Arthritis causes bone erosion via osteoclast/osteoblast imbalance.
• Orai1 calcium channel is crucial for osteoclast maturation.
• The small molecule ELP-004 targets Transient Receptor Potential Canonical (TRPC) channels.

Purpose of the Study:

• To investigate the role of TRPC channels in inflammatory bone erosion.
• To determine the effect of ELP-004 on osteoclast maturation and bone erosion.
• To identify the therapeutic potential of targeting TRPC channels in inflammatory arthritis.

Main Methods:

• Assessing osteoclast maturation in murine and human myeloid cells.
• Utilizing TRPC4 knockout and TRPC(1-7) knockout mice.
• Evaluating ELP-004's effect on TNFα- or LTB4-induced osteoclastogenesis.
• Testing ELP-004 in a mouse model of rheumatoid arthritis.

Main Results:

• ELP-004 minimally affected RANKL-induced osteoclast maturation but potently inhibited TNFα- or LTB4-driven maturation.
• TRPC channel deficiency preferentially impaired osteoclastogenesis induced by proinflammatory cytokines.
• ELP-004 treatment reduced bone erosion in a rheumatoid arthritis mouse model.

Conclusions:

• TRPC channels are critical mediators of inflammatory bone erosion.
• Targeting TRPC channels with ELP-004 shows therapeutic promise for inflammatory arthritis.
• ELP-004's primary target is TRPC channels, relevant for preclinical development.